Poster Presentation Sessions
Wednesday |
Thursday |
4 December,
2024|
Session 01
|
Session 02
|
Session 03
|
Session 04
|
Session 05
|
Session 06
|
Session 07
|
Session 08
|
 Time: |
14:00 – 15:30 |
 Adjudicators: |
Professor Gary Lau, Department of Medicine Professor David Shih, School of Biomedical Sciences |
| Presentation No. | Presentation Title and Student | ||
|---|---|---|---|
|
P8
02
|
Near-Infrared Light-Activatable Nanoaggregates for Precise Drug Delivery
|
||
|
P8
03
|
Purification of Full-Length Nidogen-1 for Structural Resolution
|
||
|
P8
04
|
Treating T-cell malignancies with T cells expressing bispecific chimeric antigen receptors
|
||
|
P8
05
|
SLFN11 sensitizes hepatocellular carcinoma to PARP inhibitor Olaparib
|
||
|
P8
06
|
CD161-LLT1 Inhibits Antitumor Activity of Vγ9Vδ2-T Cells
|
||
|
P8
07
|
A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective
antibodies against avian N2 neuraminidases
|
||
|
P8
08
|
Adeno-associated virus with liver-targeting promoter induces long-term in vivo expression of a
highly potent bi-specific neutralizing antibody against HIV-1
|
||
|
P8
09
|
The Immune Microenvironment of IDH1 Mutant Intrahepatic Cholangiocarcinoma
(ICC)
|
||
|
P8
10
|
Screening and evaluating HIV-1 specific antibodies cloning from Δ42PD-1 positive B cells
|
||
|
P8
11
|
The VEGFA-Mediated Angiogenesis of Bone Marrow Mesenchymal Stem Cells is Driven Under the
Paracrine Signalling of Neuroblastoma Cells.
|
||
|
P8
12
|
Deciphering Taste Loss Mechanisms in SARS-CoV-2 Infection
|
||
|
P8
13
|
Light-responsive Nanoparticles Enhance Anti-Cancer Immune Response by Combinational Photodynamic
Therapy
|
||
|
P8
14
|
Tumor-Derived IL18BP Drives Resistance to anti-PD-1 Blockade in Hepatocellular
Carcinoma
|
